Cloning and genomic organization of the human transforming growth factor-β type I receptor gene

Genomics

Volumn 46, Issue 2, 1997, Pages 278-283

  Vellucci, Vincent F ^a   Reiss, Michael ^a  

^a YALE CANCER CENTER   (United States)

Author keywords

Activin; Exon; Growth factor beta; Intron; Receptor; Transforming

Indexed keywords

PROTEIN SERINE THREONINE KINASE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL CYCLE; EXON; GENE; GENE STRUCTURE; HUMAN; INTRON; MOLECULAR CLONING; PRIORITY JOURNAL; RECEPTOR BINDING;

EID: 0031453669     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.1997.5023     Document Type: Article

References (35)

1. Anders, R. A., and Leof, E. B. (1996). Chimeric granulocyte/macrophage colony-stimulating factor transforming growth factor-beta (TGF-beta) receptors define a model system for investigating the role of homomeric and heteromeric receptors in TGF-beta signaling. J. Biol. Chem. 271: 21758-21766.
2. Baldwin, R. L., Friess, H., Yokoyama, M., Lopez, M. E., Kobrin, M. S., Buchler, M. W., and Korc, M. (1996). Attenuated ALK5 receptor expression in human pancreatic cancer: Correlation with resistance to growth inhibition. Int. J. Cancer 67: 283-288.
3. Bloom, B. B., Humphries, D. E., Kuang, P.-P., Fine, A., and Goldstein, R. H. (1996). Structure and expression of the promoter for the R4/ALK5 human type I transforming growth factor-β receptor: Regulation by TGFβ. Biochim. Biophys. Acta 1312: 243-248.
4. Carcamo, J., Weis, F. M., Ventura, F., Wieser, R., Wrana, J. L., Attisano, L., and Massague, J. (1994). Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin. Mol. Cell. Biol. 14: 3810-3821.
5. Chen, R.-H., and Derynck, R. (1994). Homomeric interactions between type II Transforming Growth Factor-β receptors. J. Biol. Chem. 269: 22868-22874.
6. Chen, X., Rubock, M. J., and Whitman, M. (1996). A transcriptional partner for MAD proteins in TGFβ signaling. Nature 383: 691-696.
7. Datto, M. B., Li, Y., Panus, J. F., Howe, D. J., Xiong, Y., and Wang, X. F. (1995). Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc. Natl. Acad. Sci. USA 92: 5545-5549.
8. De Jonge, R. R., Garrigue-Antar, L., Vellucci, V. F., and Reiss, M. (1997). Frequent inactivation of the transforming growth factor type II receptor in small cell lung carcinoma cells. Oncol. Res. 9: 89-98.
9. Derynck, R., and Zhang, Y. (1996). Intracellular signalling: The Mad way to do it. Curr. Biol. 6: 1226-1229.
10. Eppert, K., Scherer, S. W., Ozcelik, H., Pirone, R., Hoodless, P., Kim, H., Tsui, L.-C., Bapat, B., Gallinger, S., Andrulis, I., Thomsen, G. H., Wrana, J. L., and Attisano, L. (1996). MADR2 maps to 18q21 and encodes a TGF-β MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 86: 543-552.
11. Franzén, P., Ten Dijke, P., Ichijo, H., Yamashita, H., Schulz, P., Heldin, C.-H., and Miyazono, K. (1993). Cloning of a TGFβ type I receptor that forms a heterodimeric complex with the TGFβ type II receptor. Cell 75: 681-692.
12. Fynan, T. M., and Reiss, M. (1993). Resistance to inhibition of cell growth by Transforming Growth Factor-β and its role in oncogenesis. Crit. Rev. Oncogenesis 4: 493-540.
13. Garrigue-Antar, L., Munoz-Antonia, T., Antonia, S. J., Gesmonde, J., Vellucci, V. F., and Reiss, M. (1995). Missense mutations of the transforming growth factor beta type II receptor in human head and neck squamous carcinoma cells. Cancer Res. 55: 3982-3987.
14. Garrigue-Antar, L., Souza, R. F., Vellucci, V. F., Meltzer, S. J., and Reiss, M. (1996). Loss of transforming growth factor-β type II receptor gene expression in human esophageal cancer. Lab. Invest. 75: 263-272.
15. Hahn, S. A., Schutte, M., Hoque, A. T., Moskaluk, C. A., da Costa, L. T., Rozenblum, E., Weinstein, C. L., Fischer, A., Yeo, C. J., Hruban, R. H., and Kern, S. E. (1996). DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271: 350-353. [See comments]
16. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 371: 257-261.
17. Johnson, D. W., Berg, J. N., Baldwin, M. A., Gallione, C. J., Marondel, I., Yoon, S. J., Stenzel, T. T., Speer, M., Pericak-Vance, M. A., Diamond, A., Guttmacher, A. E., Jackson, C. E., Attisano, L., Kucherlapati, R., Porteous, M. E., and Marchuk, D. A. (1996). Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nature. Genet. 13: 189-195.
18. Kim, I. Y., Ahn, H. J., Zelner, D. J., Shaw, J. W., Sensibar, J. A., Kim, J. H., Kato, M., and Lee, C. (1996). Genetic change in transforming growth factor beta (TGF-beta) receptor type I gene correlates with insensitivity to TGF-beta 1 in human prostate cancer cells. Cancer Res. 56: 44-48.
19. Lagna, G., Hata, A., Hemmati-Brivanlou, A., and Massague, J. (1996). Partnership between DPC4 and SMAD proteins in TGF-β signalling pathways. Nature 383: 832-836.
20. Liu, F., Hata, A., Baker, J. C., Doody, J., Carcamo, J., Harland, R. M., and Massague, J. (1996). A human Mad protein acting as a BMP-regulated transcriptional activator. Nature 381: 620-622.
21. Luo, K., and Lodish, H. F. (1996). Signaling by chimeric erythropoietin-TGF-beta receptors: Homodimerization of the cytoplasmic domain of the type I TGF-beta receptor and heterodimerization with the type II receptor are both required for intracellular signal transduction. EMBO J. 15: 4485-4496.
22. Macias-Silva, M., Abdollah, S., Hoodless, P. A., Pirone, R., Attisano, L., and Wrana, J. L. (1996). MADR2 is a substrate of the TGF-β receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell 87: 1215-1224.
23. Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., Brattain, M., and Willson, J. K. V. (1995). Inactivation of the type II TGFβ receptor in colon cancer cells with microsatellite instability. Science 268: 1336-1338.
24. Massague, J. (1996). TGF-β Signaling: Receptors, transducers, and MAD proteins. Cell 85: 947-950.
25. Massagué, J., Attisano, L., and Wrana, J. L. (1994). The TGFβ family and its composite receptors. Trends Cell Biol. 4: 172-178.
26. McAllister, K. A., Baldwin, M. A., Thukkani, A. K., Gallione, C. J., Berg, J. N., Porteous, M. E., Guttmacher, A. E., and Marchuk, D. A. (1995). Six novel mutations in the endoglin gene in hereditary hemorrhagic telangiectasia type 1 suggest a dominant-negative effect of receptor function. Hum. Mol. Genet. 4: 1983-1985.
27. Park, K., Kim, S.-J., Bang, Y.-J., Park, J.-G., Kim, N. K., Roberts, A. B., and Sporn, M. B. (1994). Genetic changes in the transforming growth factor β (TGFβ) type II receptor gene in human gastric cancer cells: Correlation with sensitivity to TGFβ. Proc. Natl. Acad. Sci. USA 91: 8772-8776.
28. Roberts, A. B., and Sporn, M. B. (1993). Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta). Growth Factors 8: 1-9.
29. Shizuya, H., Birren, B., Kim, U.-J., Mancino, V., Slepak, T., Tachiiri, Y., and Simon, M. (1992). Cloning and stable maintenance of 300-kilobase-pair fragments of human DNA in Escherichia coli using an F-factor-based vector. Proc. Natl. Acad. Sci. USA 89: 8794-8797.
30. Wieser, R., Attisano, L., Wrana, J. L., and Massagué, J. (1993). Signaling activity of Transforming Growth Factor β type II receptors lacking specific domains in the cytoplasmic region. Mol. Cell. Biol. 13: 7239-7247.
31. Wieser, R., Wrana, J. L., and Massague, J. (1995). GS domain mutations that constitutively activate T beta R-I, the downstream signaling component in the TGF-beta receptor complex. EMBO J. 14: 2199-2208.
32. Wrana, J. L., Attisano, L., Cárcamo, J., Zentella, A., Doody, J., Laiho, M., Wang, X.-F., and Massagué, J. (1992). TGFβ signals through a heteromeric protein kinase receptor complex. Cell 71: 1003-1014.
33. Wrana, J. L., Attisano, L., Wieser, R., Ventura, F., and Massagué, J. (1994). Mechanism of activation of the TGFβ receptor. Nature 370: 341-347.
34. Xu, J., Matsuzaki, K., McKeehan, K., Wang, F., Kan, M., and McKeehan, W. L. (1994). Genomic structure and cloned cDNAs predict that four variants in the kinase domain of serine/threonine kinase receptors arise by alternative splicing and poly(A) addition. Proc. Natl. Acad. Sci. USA 91: 7957-7961.
35. Zhang, Y., Feng, X.-H., Wu, R.-Y., and Derynck, R. (1996). Receptor-associated Mad homologues synergize as effectors of the TGF-β response. Nature 383: 168-172.